Highlights in resistance mechanism pathways for combination therapy

JMA Delou, ASO Souza, LCM Souza, HL Borges - Cells, 2019 - mdpi.com
Combination chemotherapy has been a mainstay in cancer treatment for the last 60 years.
Although the mechanisms of action and signaling pathways affected by most treatments with …

Advantages of the combinatorial molecular targeted therapy of head and neck cancer—A step before anakoinosis-based personalized treatment

R Kleszcz - Cancers, 2023 - mdpi.com
Simple Summary Head and Neck Squamous Cell Carcinoma (HNSCC) is a major threat to
public health around the world. Its occurrence is linked to genetic events and environmental …

The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation

D Yu, X Liu, G Han, Y Liu, X Zhao, D Wang… - Cell Communication and …, 2019 - Springer
Background Accumulation of immunosuppressive protein programmed death-ligand 1 (PD-
L1) has been documented in several cancers and contributes to the evasion of the host …

ABCB1 and ABCG2 overexpression mediates resistance to the phosphatidylinositol 3-kinase inhibitor HS-173 in cancer cell lines

CP Wu, CY Hung, YJ Hsieh, M Murakami, YH Huang… - Cells, 2023 - mdpi.com
Constitutive activation of the phosphoinositide-3-kinase (PI3K)/Akt signaling pathway is
crucial for tumor growth and progression. As such, this pathway has been an enticing target …

PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy

FC Chuang, CC Wang, JH Chen, TZ Hwang, SA Yeh… - PLoS …, 2021 - journals.plos.org
Approximately 500,000 new cases of head and neck squamous cell carcinoma (HNSCC)
are reported annually. Radiation therapy is an important treatment for oral squamous cell …

Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene

ME Heft Neal, AC Birkeland, AD Bhangale, J Zhai… - BMC cancer, 2021 - Springer
Abstract Background Sinonasal Undifferentiated Carcinoma (SNUC) is a rare and
aggressive skull base tumor with poor survival and limited treatment options. To date …

Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma

NL Michmerhuizen, ML Ludwig, AC Birkeland… - Head & …, 2022 - Wiley Online Library
Background Head and neck squamous cell carcinoma (HNSCC) is a debilitating disease
with poor survival. Although epidermal growth factor receptor (EGFR)‐targeting antibody …

IGF2 mediates resistance to isoform-selective-inhibitors of the PI3K in HPV positive head and neck cancer

M Badarni, M Prasad, A Golden, B Bhattacharya… - Cancers, 2021 - mdpi.com
Simple Summary In the current study, we delineate the molecular mechanisms of acquisition
of resistance to two isoform-selective inhibitors of PI3K (isiPI3K), alpelisib and taselisib, in …

Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma

ML Ludwig, NL Michmerhuizen, J Wang… - Archives of Oral …, 2023 - Elsevier
Background Head and neck squamous cell carcinoma (HNSCC) is a debilitating disease
with poor survival rates. While the epidermal growth factor receptor (EGFR)-targeting …

[HTML][HTML] Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer

GD Wilson, TG Wilson, A Hanna, M Dabjan… - Clinical and translational …, 2021 - Elsevier
Abstract Background and Purpose There has been little success targeting individual genes
in combination with radiation in head and neck cancer. In this study we investigated whether …